METHOTREXATE
NDC 62332-730, METHOTREXATE, tablet, from Alembic Pharmaceuticals Inc..
- Product NDC
- 62332-730
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217552
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62332-730 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM2.5 mg/1
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62332-730-31 | 62332073031 | 100 TABLET in 1 BOTTLE (62332-730-31) |
| 62332-730-36 | 62332073036 | 36 TABLET in 1 BOTTLE (62332-730-36) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/04a95db9-a124-4b97-bd71-1c37a6b3b0c8NADAC price for package 62332073031
GET /v1/drugs/nadac/62332073031NADAC price for package 62332073036
GET /v1/drugs/nadac/62332073036
Use it
Look up 62332-730 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62332-730 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62332-730. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.